VENUSREM Intraday Analysis...

VENUSREM Share Price

Open 104.40 Change Price %
High 104.40 1 Day -0.75 -0.73
Low 101.50 1 Week 3.45 3.50
Close 102.15 1 Month 1.90 1.90
Volume 41150 1 Year 17.00 19.96
52 Week High 121.70
52 Week Low 84.00
VENUSREM Important Levels
Resistance 2 104.84
Resistance 1 103.73
Pivot 102.68
Support 1 100.57
Support 2 99.46
NSE INDIA Most Active Stocks
TV18BRDCST 50.55 9.65%
GMRINFRA 18.65 10.03%
SUZLON 14.15 4.04%
JAICORPLTD 189.65 17.76%
RCOM 13.55 -0.37%
JPASSOCIAT 18.90 0.80%
PRAJIND 117.10 10.52%
GAMMNINFRA 2.95 -4.84%
MERCATOR 41.30 4.03%
IBREALEST 208.25 -2.00%
More..
NSE INDIA Top Gainers Stocks
KSERASERA 0.20 33.33%
ZUARIGLOB 266.75 20.00%
COMPINFO 31.50 20.00%
DUCON 41.15 19.97%
CAMLINFINE 110.40 19.74%
HIGHGROUND 11.00 19.57%
JAICORPLTD 189.65 17.76%
TARAJEWELS 22.15 16.89%
GOLDIAM 91.00 16.00%
ROHLTD 175.10 14.37%
More..
NSE INDIA Top Losers Stocks
PKTEA 275.85 -8.79%
NEULANDLAB 1037.70 -8.46%
RAJSREESUG 62.25 -7.71%
EASUNREYRL 22.30 -6.89%
GILLANDERS 81.75 -6.36%
TEAMLEASE 1958.85 -6.16%
SIMBHALS 26.65 -5.66%
TPLPLASTEH 598.60 -5.63%
OILCOUNTUB 49.30 -5.28%
SUJANAUNI 0.90 -5.26%
More..

Venus Remedies Limited (NSE: VENUSREM)

VENUSREM Technical Analysis 3
As on 24th Nov 2017 VENUSREM Share Price closed @ 102.15 and we RECOMMEND Buy for LONG-TERM with Stoploss of 100.04 & Buy for SHORT-TERM with Stoploss of 101.27 we also expect STOCK to react on Following IMPORTANT LEVELS.
VENUSREM Target for November
1st Target up-side 112.82
2nd Target up-side 117.88
3rd Target up-side 122.94
1st Target down-side 98.38
2nd Target down-side 93.32
3rd Target down-side 88.26
VENUSREM Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 50.30 Sideways
MFI (14) MFI is 58.23 Sideways
CCI (20) CCI is -6.01 Sideways
WILLIAM %R (14) William %R is -50.92 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 97.44
10 Day Avg Volume Traded -22.26 % Less then 10 Day Average Volume
VENUSREM Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.venusremedies.com
VENUSREM Address
VENUSREM
Plot 51-52, Industrial Area
Phase I
Panchkula, 134113
India
Phone: 91 17 2325 0571
Fax: 91 17 2256 5566
VENUSREM Latest News
Venus Remedies bags patent for antibiotic Vancoplus   Hindu Business Line   - 09th Feb 15
Venus Remedies receives approval for pain reliever drug Trois in Singapore   Business Standard   - 30th Sep 14
Venus Remedies eyes tie-ups for out-licensing drugs   Economic Times   - 23rd Sep 14
Venus Remedies Ltd updates on downgrade by CRISIL   Equity Bulls   - 17th Sep 14
Venus Remedies looking to raise $20M through QIP   VC Circle   - 04th Sep 14
Venus Remedies - Extension of time for holding AGM   Moneycontrol.com   - 01st Sep 14
Venus Remedies Ltd rallies on strategic tie-up with Teva   Economic Times   - 27th Aug 14
Venus Remedies Ltd. : Venus Remedies signs MoU for Elores with South African ...   4-traders (press release)   - 17th Dec 13
Mr. Pawan Chaudhary, Managing Director, Venus Remedies Ltd   India Infoline.com   - 20th May 11
Pawan Chaudhary, MD, Venus Remedies Ltd.   India Infoline.com   - 17th Aug 10
Interactive Technical Analysis Chart Venus Remedies Limited ( VENUSREM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Venus Remedies Limited
VENUSREM Business Profile
Venus Remedies Limited manufactures and trades medicines in India and internationally. It primarily offers fixed dosage injectable products. The company’s product portfolio includes approximately 75 products in various therapeutic segments comprising oncology, anti infective, neurology, cardiology, orthopedic, pediatrics, and surgery. It offers its products under the Mebatic, Calridol, Moximicin, Neurotol, Glutapep, Doxol, Paxol, Citabol, Epirol, Ronem, Immunox, Pimcef, Fejet IV, Parin-E, Vanconex, Elores, Supime, Tobracef, Vancoplus, Potentox, Pirotum, and other brand names. The company was incorporated in 1989 and is headquartered in Panchkula, India.